The FY2025 (Dec) proxy of Vericel names 19 peer companies for pay. Pay versus performance data of Vericel for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| PTC Therapeutics | ||
| Supernus Pharmaceuticals | ||
| GLAUKOS | ||
| iRhythm Holdings | ||
| TransMedics Group | ||
| AtriCure | ||
| Travere Therapeutics | ||
| Artivion | ||
| Beam Therapeutics | ||
| Alphatec Holdings, Inc. | Not disclosed | Not disclosed |
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Corcept Therapeutics | Not disclosed | Not disclosed |
| Inari Medical, Inc. | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| PROCEPT BioRobotics | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| RxSight, Inc. | Not disclosed | Not disclosed |
| STAAR Surgical Company | Not disclosed | Not disclosed |
| Tandem Diabetes Care | Not disclosed | Not disclosed |
19 companies
PSU comparator group
The companies that relative total shareholder return is measured against for performance stock units.
| NASDAQ Biotechnology Index (index) | Not disclosed | Not disclosed |
1 company
Changes by year
FY2023 (Dec) proxy
- RemovedFlexion Therapeutics, Inc.pay peer groupdue to its acquisition
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.